Qingdao Vland Biotech INC. (SHA:603739)
China flag China · Delayed Price · Currency is CNY
12.93
-0.17 (-1.30%)
Sep 2, 2026, 2:09 PM CST

SHA:603739 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
230.28244.16248.73239.6213.87311.83
Trading Asset Securities
241.83224.87199.34292.05212.02170.43
Cash & Short-Term Investments
472.11469.02448.07531.64425.89482.27
Cash Growth
34.80%4.68%-15.72%24.83%-11.69%38.83%
Accounts Receivable
446.49409.27376.58330.26307.72254.31
Other Receivables
38.5341.9728.6825.8332.5136.3
Receivables
485.03460.24405.26356.09347.91298.37
Inventory
242.86226.37188.95205.41173.63157.02
Prepaid Expenses
-01.590.120.130.06
Other Current Assets
38.522.9825.3130.6821.8434.1
Total Current Assets
1,2381,1791,0691,124969.4971.82
Property, Plant & Equipment
1,4731,5241,5601,5051,260843.51
Long-Term Investments
15.3476.2598.6480.8477.198.59
Goodwill
84.284.284.284.220.2620.26
Other Intangible Assets
137.88126.72131.13139.74135.63131.46
Long-Term Deferred Tax Assets
24.1323.5516.9918.0613.6412.03
Long-Term Deferred Charges
1.211.261.471.411.280.37
Other Long-Term Assets
41.2825.5419.1480.57101.57233.72
Total Assets
3,0163,0402,9813,0342,5792,222

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
207.01194.41224.56231.95147.36112.11
Accrued Expenses
27.09116.92102.0991.7674.2672.89
Short-Term Debt
602.99582.87581.63568.97374.22135.93
Current Portion of Long-Term Debt
15.9436.1240.0392.88-1
Current Income Taxes Payable
16.968.3410.068.4311.678.95
Current Unearned Revenue
19.0414.2511.5110.677.4913.62
Other Current Liabilities
112.9654.1761.5783.5130.127.83
Total Current Liabilities
1,0021,0071,0311,088645.09372.33
Long-Term Debt
49.9159.7913.9662.0614999
Long-Term Unearned Revenue
52.8959.5863.9755.2647.9660.45
Long-Term Deferred Tax Liabilities
1.341.381.463.022.722.88
Other Long-Term Liabilities
1.111.110.150.150.171.52
Total Liabilities
1,1071,1291,1111,209844.93536.18

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
253.03253.03253.03253.03252.44252.08
Additional Paid-In Capital
702.9702.9702.9712.08705.09693.84
Retained Earnings
854.66841.4796.9759.56704.12674.61
Comprehensive Income & Other
-14.8-14.81-15.1-16.38-16.96-16.03
Total Common Equity
1,7961,7831,7381,7081,6451,605
Minority Interest
112.9128.2132.3117.0989.2281.07
Shareholders' Equity
1,9091,9111,8701,8251,7341,686
Total Liabilities & Equity
3,0163,0402,9813,0342,5792,222

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
668.83678.78635.62723.92523.22235.93
Net Cash (Debt)
-196.72-209.76-187.55-192.27-97.33246.34
Net Cash Growth
------11.88%
Net Cash Per Share
-0.77-0.84-0.75-0.76-0.381.00
Filing Date Shares Outstanding
258.88253.03253.03253.03252.62252.08
Total Common Shares Outstanding
258.88253.03253.03253.03252.44252.08
Working Capital
236.52171.5337.7535.77324.31599.5
Book Value Per Share
6.947.046.876.756.526.36
Tangible Book Value
1,5741,5721,5221,4841,4891,453
Tangible Book Value Per Share
6.086.216.025.875.905.76
Buildings
-1,009932.34931.6449.85398.83
Machinery
-1,095943.65929.21474.19443.58
Construction In Progress
-37.4203.8175.14704.43315.72